High levels of C-reactive protein in the peripheral blood during visceral leishmaniasis predict subsequent development of post kala-azar dermal leishmaniasis

Acta Tropica

Volumn 75, Issue 1, 2000, Pages 35-38

  Gasim, Soha ^a,b   Theander, Thor G ^a,b   Elhassan, Ahmed M ^c  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b Mental Health Center Glostrup   (Denmark)

^c UNIVERSITY OF KHARTOUM   (Sudan)

Author keywords

C reactive protein (CRP); Post kala azar dermal leishmaniasis (PKDL); Visceral leishmaniasis

Indexed keywords

C REACTIVE PROTEIN; INTERLEUKIN 10; STIBOGLUCONATE SODIUM;

ARTICLE; ENZYME LINKED IMMUNOSORBENT ASSAY; FOLLOW UP; HIGH RISK PATIENT; HUMAN; LEISHMANIASIS; SKIN LEISHMANIASIS; VISCERAL LEISHMANIASIS;

BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; LEISHMANIASIS, CUTANEOUS; LEISHMANIASIS, VISCERAL; PREDICTIVE VALUE OF TESTS;

NASO HEXACANTHUS; PROTOZOA;

EID: 0033975572     PISSN: 0001706X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0001-706X(99)00089-3     Document Type: Article

References (10)

1. Cenini P., Berhe N., Hailu A., McGinnes K., Frommel D. Mononuclear cell subpopulations and cytokine levels in human visceral leishmaniasis before and after chemotherapy. J. Infect. Dis. 168:1993;986-993.
2. El Hassan A.M., Ghalib H.W., Zijlstra E.E., Eltoum I.A., Satti M., Ali M.S., Ali H.M.A. Post kala-azar dermal leishmaniasis in the Sudan: clinical features, pathology and treatment. Trans. R. Soc. Trop. Med. Hyg. 86:1992;245-248.
3. Gasim S., El Hassan A.M., Khalil E.A.G., Ismail A., Kadaru A.M.Y., Kharazmi A., Theander T.G. High levels of plasma IL-10 and expression of IL-10 by keratinocytes during visceral leishmaniasis predict subsequent development of post kala-azar dermal leishmaniasis. Clin. Exp. Immunol. 111:1998;64-69.
4. Gillespie S.H., Dow C., Raynes J.G., Behrens R.H., Chiodini P.L., McAdam K.P.W.J. Measurement of acute phase proteins for assessing severity of Plasmodium falciparum. J. Clin. Pathol. 44:1991;228-231.
5. Kushner I. The phenomenon of acute phase response. Ann. New York Acad. Sci. 389:1982;39-48.
6. Osman O.F., Kager P.A., Zijlstra E.E., El Hassan A.M., Oskam L. Use of PCR on lymph node samples as test of cure of visceral leishmaniasis. J. Clin. Microbiol. 36:1998;1621-1624.
7. Steel D.M., Whitehead A.S. The major acute phase reactants: C-reactive protein serum amyloid P component and serum amyloid A protein. Immunol. Today. 15(2):1994;81-88.
8. Van-der-Poll T., Zijlstra E.E., Mevissen M. Interleukin 6 during active visceral leishmaniasis and after treatment. Clin. Immunol. Immunopathol. 77:1995;111-114.
9. Wasunna K.M., Raynes J.G., Were J.B.O., Muigai R., Sherwood J., Gachihi G., Carpenter L., McAdam K.P.W.J. Acute phase protein concentrations predict parasite clearance rate during therapy for visceral leishmaniasis. Trans. R. Soc. Trop. Med. Hyg. 89:1995;678-681.
10. Zijlstra E.E., El Hassan A.M., Ismail A., Ghalib H.W. Endemic kala-azar in Eastern Sudan: a longitudinal study on the incidence of clinical and subclinical infection and post kala-azar dermal leishmaniasis. Am. J. Trop. Med. Hyg. 51:1994;826-836.